Biosplice Therapeutics is in the medical research and development for tissue-level regeneration. With their platform's origins in small molecule-based Wnt pathway modulation, they develop therapeutics to address a range of degenerative diseases, regenerative medicine, and oncology.Samumed adopted a fresh operating philosophy from thebeginning — one based on a goal of building a broad technology platform aimed at modulating regenerative pathways to improve patient health.

Biotechnology

Health Care

Biosplice Therapeutics

Cevdet Samikoglu

SAM NAMIQ

Scott Bulcao

Osman Kibar

John Hill

Jeymi Tambiah

Erich Horsley

Christopher Swearingen

The Leadership Team at Biosplice Therapeutics formulates strategic direction, oversees high-level operations, and ensures the alignment of research and development activities with company goals in tissue-level regeneration. They are responsible for making key financial decisions, driving clinical and external innovation, managing legal matters, and fostering a collaborative environment to advance therapeutic solutions for degenerative diseases, regenerative medicine, and oncology.

Leadership Team

Research and Development

Clinical Operations

Leadership Team

About

Team members

Other teams at Biosplice Therapeutics

Research and Development

Clinical Operations